StudyFinder

Zymfentra (Infliximab-dyyb) REal World Cohort STudy

Status: Recruiting

The goal of this study is to learn more about the safety and effectiveness of Zymfentra treatment for people with inflammatory bowel disease (IBD), Crohn’s disease, and ulcerative colitis. Researchers will collect information about symptoms, treatment response, and side effects over time to better understand how Zymfentra works for people with IBD.

I'm interested

Sex: Male or Female
Age Group: 18 years and over
This study is NOT accepting healthy volunteers
Inclusion Criteria:

• diagnosis of Crohn’s disease (CD), ulcerative colitis (UC), or inflammatory bowel disease unclassified (IBDU)
• starting or switching to Zymfentra treatment for inflammatory bowel disease
Conditions:

Digestive & Liver Health

Keywords:

Clinics and Surgery Center (CSC), Crohn's disease, inflammatory bowel disease, Ulcerative colitis

Study Contact: Sharon Lopez - skunkel@umn.edu
Principal Investigator: Byron Vaughn
IRB Number: STUDY00027842

Back